von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

Karim Kentouche1, Felix Zintl, Dorothea Angerhaus

  • 1Department of Hematology, Children's Hospital, Friedrich Schiller University, Jena, Germany. Karim.Kentouche@med.uni-jena.de

Insights

Transplantation-associated microangiopathy (TAM) involves reduced ADAMTS13 activity, an enzyme crucial for regulating von Willebrand factor. This study observed declining ADAMTS13 levels post-transplant, particularly during severe TAM episodes.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Vascular Biology

Background:

  • Transplantation-associated microangiopathy (TAM) is a serious stem cell transplant complication with a poor prognosis.
  • TAM shares features with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
  • Defective VWF proteolysis, potentially due to reduced ADAMTS13 activity, is implicated in TAM.

Observation:

  • This study monitored ADAMTS13 activity in 28 patients undergoing allogeneic stem cell transplantation.
  • ADAMTS13 activity, initially normal, decreased significantly within 8 weeks post-transplant.
  • Most patients showed eventual normalization of ADAMTS13 activity.

Findings:

  • Low ADAMTS13 activity did not consistently correlate with clinical TAM.
  • Two patients with severe TAM exhibited the lowest ADAMTS13 activity levels.
  • Plasma exchange failed to restore ADAMTS13 levels in these patients, suggesting enzyme inactivation or consumption.

Implications:

  • ADAMTS13 deficiency or dysfunction may play a role in TAM pathogenesis.
  • Further research is needed to elucidate the precise mechanisms of ADAMTS13 involvement in TAM.
  • Understanding ADAMTS13 dynamics could lead to improved TAM diagnostics and therapeutics.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...